Bioinformatics Clinical Trials Genetics 
XTalks
APRIL 21, 2023
Biotech company Ultima Genomics has joined forces with Genome Insight, a bioinformatics-based biomedicine company, to overcome the caveat of cost and quality in WGS. Genome sequencing requires a powerful sequencer to decode the genetic makeup and an equally powerful analysis platform to make sense of the data generated.
pharmaphorum
SEPTEMBER 14, 2020
Last week geneticist Dr Charles Steward shared with us his experiences of searching for a genetic cause for his children’s rare neurological diseases. While it is a very rare form of epilepsy, it is such a cheap and harmless medication that it is often used as a first-line therapy for infants in intensive care who have no genetic diagnosis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
SEPTEMBER 28, 2020
The test is based on the detection of actionable genes – genes with known driver mutations that can be targeted by an approved therapy (or investigational therapies in clinical trials). Based on the genetic biomarker(s) identified, the most effective therapy targeting the specific molecular marker can be selected.
Scienmag
DECEMBER 10, 2020
Clinical trial at Moores Cancer Center at UC San Diego Health individualizes TIL therapy for patients with melanoma or head and neck cancers Credit: UC San Diego Health Sciences Since 2016, Bernard Thurman has undergone traditional treatments, experimental therapies and surgeries to counter the cancer within him, but nothing has successfully eradicated (..)
XTalks
MAY 20, 2022
A Clinical Scientist will perform a wide range of duties depending on the focus of their research. Here is a summary of the kind of work you can expect to do: Design and implement clinical trials for human diseases and treatment. What Field Can You Work in as a Clinical Scientist? Clinical Pharmaceutical Science.
pharmaphorum
MARCH 28, 2022
AION Labs’ third call for applications seeks computational biologists, bioinformatics and cheminformatics scientists, AI researchers, and antibody or protein engineers at academic and industry research labs worldwide to assemble a fully funded start-up company. From there, they evaluate what kind of antibodies are produced.
The Pharma Data
JULY 27, 2021
This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. is a clinical stage biotechnology company developing a new class of biologics, Human Heavy-Chain Antibodies (UniAb®), for the treatments of cancer, autoimmunity, and infectious diseases.
Expert insights. Personalized for you.
97 
Let's personalize your content